This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of an acute angina attack

Authoring team

In an acute attack of angina, any precipitating factor - exercise in exertional angina, or lying down in decubitus angina should be stopped, and a fresh glyceryl trinitrate tablet (0.5 mg) should be placed under the tongue. Pain usually recedes within 3 minutes.

When the pain is relieved the trinitrate tablet is spat out or swallowed, in order to minimise the risk of developing side effects, in particular a severe pounding headache.

Frequent or prolonged angina attacks need urgent review and consideration for urgent hospital admission because of possible unstable angina or myocardial infarction.

NICE state with respect to using short-acting nitrate in angina

  • offer a short-acting nitrate for preventing and treating episodes of angina.
    • advise people with stable angina:
      • how to administer the short-acting nitrate
      • to use it immediately before any planned exercise or exertion
      • that side effects such as flushing, headache and light-headedness may occur
      • to sit down or find something to hold on to if feeling light-headed
    • when a short-acting nitrate is being used to treat episodes of angina, advise people:
      • to repeat the dose after 5 minutes if the pain has not gone
      • to call an emergency ambulance if the pain has not gone 5 minutes after taking a second dose (1)

Reference:

 


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.